rs13266634
|
|
T |
1.000 |
SusceptibilityMutation |
CLINVAR |
|
|
|
rs4402960
|
|
T |
1.000 |
SusceptibilityMutation |
CLINVAR |
|
|
|
rs12255372
|
|
T |
0.900 |
SusceptibilityMutation |
CLINVAR |
|
|
|
rs11196205
|
|
C |
0.800 |
SusceptibilityMutation |
CLINVAR |
|
|
|
rs137853240
|
|
A |
0.800 |
SusceptibilityMutation |
CLINVAR |
|
|
|
rs3792267
|
|
A |
0.770 |
SusceptibilityMutation |
CLINVAR |
|
|
|
rs137852783
|
|
A |
0.760 |
SusceptibilityMutation |
CLINVAR |
|
|
|
rs2975760
|
|
C |
0.730 |
SusceptibilityMutation |
CLINVAR |
|
|
|
rs5030952
|
|
T |
0.730 |
SusceptibilityMutation |
CLINVAR |
|
|
|
rs137852786
|
|
A |
0.720 |
SusceptibilityMutation |
CLINVAR |
|
|
|
rs3842570
|
|
AGATGATTCTGTCCCAGGAGCCGGGAGGAGGGT |
0.720 |
SusceptibilityMutation |
CLINVAR |
|
|
|
rs137852785
|
|
C |
0.710 |
SusceptibilityMutation |
CLINVAR |
|
|
|
rs200998587
|
|
T |
0.710 |
SusceptibilityMutation |
CLINVAR |
|
|
|
rs2070895
|
|
A |
0.710 |
SusceptibilityMutation |
CLINVAR |
|
|
|
rs137852784
|
|
T |
0.700 |
SusceptibilityMutation |
CLINVAR |
|
|
|
rs141804752
|
|
G |
0.700 |
SusceptibilityMutation |
CLINVAR |
|
|
|
rs182349376
|
|
T |
0.700 |
SusceptibilityMutation |
CLINVAR |
|
|
|
rs184917682
|
|
C |
0.700 |
SusceptibilityMutation |
CLINVAR |
|
|
|
rs387906779
|
|
C |
0.700 |
SusceptibilityMutation |
CLINVAR |
|
|
|
rs76474829
|
|
G |
0.700 |
SusceptibilityMutation |
CLINVAR |
|
|
|
rs80356661
|
|
T |
0.700 |
SusceptibilityMutation |
CLINVAR |
|
|
|
rs13266634
|
|
C |
1.000 |
GeneticVariation |
GWASCAT |
A genome-wide association study identifies novel risk loci for type 2 diabetes.
|
17293876 |
2007 |
rs13266634
|
|
C |
1.000 |
GeneticVariation |
GWASCAT |
Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes.
|
17463249 |
2007 |
rs13266634
|
|
|
1.000 |
GeneticVariation |
BEFREE |
In Chinese Han, we replicated the associations between 7 genetic loci and T2D, with risk allele-specific odds ratios (ORs) as follows: 1.27 (95% CI, 1.11-1.45; p = 0.0008) for CDKAL1-rs10946398, 1.26 (95% CI, 1.08-1.47; p = 0.003) for IGF2BP2-rs4402960, 1.19 (95% CI, 1.04-1.37; p = 0.009) for SLC30A8-rs13266634, 1.22 (95% CI, 1.06-1.41; p = 0.005) for CDKN2A/B-rs10811661, 1.20 (95% CI, 1.01-1.42; p = 0.03) for HHEX-rs5015480, 1.37 (95% CI, 1.19-1.69; p = 1.0 x 10(-4)) for KCNQ1-rs2237892, and 1.24 (95% CI, 1.01-1.52; p = 0.046) for FTO-rs8050136 after adjustment for age, gender, and body mass index.
|
20509872 |
2010 |
rs13266634
|
|
|
1.000 |
GeneticVariation |
BEFREE |
We replicated the association with type 2 diabetes for rs10811661 in the vicinity of CDKN2B (OR 1.20, 95% CI: 1.06-1.37, p=0.004), rs9939609 in FTO (OR 1.14, 95% CI: 1.04-1.25, p=0.006) and rs13266634 in SLC30A8 (OR 1.20, 95% CI: 1.09-1.33, p=3.9 x 10(-4)).
|
18437351 |
2008 |